SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-128781
Filing Date
2017-04-19
Accepted
2017-04-19 16:08:34
Documents
2
Period of Report
2017-06-01
Effectiveness Date
2017-04-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d313702ddef14a.htm DEF 14A 310221
2 GRAPHIC g313702pcpg01.jpg GRAPHIC 4058
  Complete submission text file 0001193125-17-128781.txt   317182
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 17770074
SIC: 2834 Pharmaceutical Preparations